Klaus Pethig
Department of Internal Medicine III-Cardiology
Friedrich Schiller University
Germany
Name/email consistency: high
- Mycophenolate mofetil for secondary prevention of cardiac allograft vasculopathy: influence on inflammation and progression of intimal hyperplasia. Pethig, K., Heublein, B., Wahlers, T., Dannenberg, O., Oppelt, P., Haverich, A. J. Heart Lung Transplant. (2004)
- Aortic valve reimplantation in ascending aortic aneurysm: risk factors for early valve failure. Pethig, K., Milz, A., Hagl, C., Harringer, W., Haverich, A. Ann. Thorac. Surg. (2002)
- Impact of vascular branching sites on focal progression of allograft vasculopathy in transplanted hearts. Pethig, K., Kofidis, T., Heublein, B., Westphal, A., Haverich, A. Atherosclerosis (2001)
- Systemic inflammatory response in cardiac allograft vasculopathy: high-sensitive C-reactive protein is associated with progressive luminal obstruction. Pethig, K., Heublein, B., Kutschka, I., Haverich, A. Circulation (2000)
- Vascular remodeling in cardiac allograft vasculopathy. Pethig, K., Heublein, B., Haverich, A. Z. Kardiol (2000)
- Cardiac allograft vasculopathy--coronary interventions and surgical options. Pethig, K., Heublein, B., Haverich, A. Z. Kardiol (2000)
- Volumetric remodeling of the proximal left coronary artery: early versus late after heart transplantation. Pethig, K., Heublein, B., Meliss, R.R., Haverich, A. J. Am. Coll. Cardiol. (1999)
- Mechanism of luminal narrowing in cardiac allograft vasculopathy: inadequate vascular remodeling rather than intimal hyperplasia is the major predictor of coronary artery stenosis. Working Group on Cardiac Allograft Vasculopathy. Pethig, K., Heublein, B., Wahlers, T., Haverich, A. Am. Heart J. (1998)